The Company intends to make a request for the review of the delisting determination. At this time, the Securities have not been suspended and will continue to trade.
Save time and jump to the most important pieces.
San Antonio, TX, May 02, 2024 (GLOBE NEWSWIRE) -- Clearday (OTCQX CLRD), a healthcare services company focused on bringing innovative products and services to the senior care industry, would like to thank Jeffrey Coleman for his services as a Board Member to Clearday since its merger back in September 2021. James Walesa, CEO and Founder of Clearday, said, "Jeff has been a staunch supporter of the cause of innovating Senior Care for years. He has brought wisdom and experience to our Board over the last three (3) years. We know Jeff will be an asset to his next company. We wish him well in his new endeavors and feel confident that he will be met with great success." Clearday seeks
New York, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp (NYSE:VHAQ, VHAQR, VHAQU))) a special purpose acquisition company (the "Company") re-affirms its commitment to the previously announced business combination with Clearday (CLRD-OTCQX), a San Antonio, Texas-based Healthcare Services company. The Company is focused on completing all of its regulatory filings to support completing the business combination with Clearday. Additionally, the Company will be appealing the recent decision by a hearings panel of the NYSE American's Committee for Review confirming the decision by the NYSE Staff to delist the Company's units, common stock and rights. As a result of that decisi
Viveon combination with Clearday continues to move forward New York, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp (NYSE:VHAQ, VHAQW, VHAQR, VHAQU))) a special purpose acquisition company (the "Company") today is pleased to reconfirm its commitment to the previously announced business combination with Clearday (CLRD-OTCQX), a San Antonio, Texas-based Healthcare Services company. Clearday's mission is to bring digital companionship to the 170 million Americans turning 50 by 2030. The companies, together with their financial advisor, ClearThink Capital, have been working diligently on the transaction and look forward to continuing to work with ClearThink after the propose
4 - Viveon Health Acquisition Corp. (0001823857) (Issuer)
4 - Viveon Health Acquisition Corp. (0001823857) (Issuer)
3 - Viveon Health Acquisition Corp. (0001823857) (Issuer)
425 - Viveon Health Acquisition Corp. (0001823857) (Subject)
8-K - Viveon Health Acquisition Corp. (0001823857) (Filer)
25-NSE - Viveon Health Acquisition Corp. (0001823857) (Subject)
The Company intends to make a request for the review of the delisting determination. At this time, the Securities have not been suspended and will continue to trade.
SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)
SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)
SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)